EP3340971
Aðferðir til meðhöndlunar á Lennox-Gastaut heilkennum með því að nota fenflúramín
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.8.2016EP published:
13.3.2024EP application number:
16840062.0
EP translation filed:
13.5.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
23.8.2036Expiry date:
23.8.2026Next due date:
31.8.2026
Title in English:
METHODS OF TREATING LENNOX-GASTAUT SYNDROME USING FENFLURAMINELanguage of the patent:
English
Timeline
Today
24.8.2016EP application
13.3.2024EP Publication
13.5.2024Translation submitted
15.6.2024Registration published
23.8.2026Expires
Owner
Name:
Zogenix International LimitedAddress:
Windlesham Campus, Sunninghill Road Windlesham, Surrey, GU20 6PP, GB
Inventor
Name:
FARR, Stephen J.Address:
Orinda, California 94563, US
Name:
GALER, Bradley S.Address:
West Chester, Pennsylvania 19382, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562209090 PDate:
24.8.2015Country:
US
Classification
Categories:
A61K 31/135, A61K 31/137, A61P 25/08
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 9.7.2024
Expires: 23.8.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 9.7.2024
Expires: 23.8.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 11.8.2025
Expires: 23.8.2026
Payer: Árnason Faktor ehf.